News

Success Begins Here

Dive into our most recent firm and portfolio updates

News Page Pear Therapeutics

Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRX

Pear Therapeutics, Inc. today announced formulary availability of its commercial products at OptumRx, Inc., the…

Arboretum_JDAugust 10, 2021

Koya Medical News Page

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases…

Arboretum_JDAugust 10, 2021

Health Scholars News Page

New VR Training From Health Scholars & The American Academy of Pediatrics Aims to Help EMS Save Children’s Lives

Health Scholars has launched Pediatric Emergency Care™, a VR training application specifically designed for EMS…

Arboretum_JDAugust 10, 2021

EQRx Home Page News Page

EQRx to Accelerate Growth with $1.8B Raise through Proposed Combination with CM Life Sciences III

EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new…

Arboretum_JDAugust 6, 2021

ConcertoCare ConcertoHealth News Page

Julian Harris, Deerfield & ConcertoCare, on Innovating Elder Care

Julian Harris, M.D., is a Partner on the Healthcare Services team at Deerfield and Chairman…

Arboretum_JDAugust 4, 2021

EQRx News Page

EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines

Collaboration leverages AbCellera’s AI-powered technology platform to identify novel antibody drug candidates for multiple disease…

Arboretum_JDAugust 4, 2021

Home Page News Page Strata Oncology

Strata Oncology Completes $90 Million Series C Financing

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDJuly 28, 2021

News Page Pear Therapeutics

Pear Therapeutics Announces Publication of Data Analysis Showing Real-World Cost Impact of ReSET-O®

Pear Therapeutics, Inc., today announced publication of a new analysis demonstrating the real-world cost impact…

Arboretum_JDJuly 28, 2021

Health Scholars News Page

Health Scholars’ Strengthens EMS Portfolio to Meet Virtual Learning Demand

Health Scholars is a cloud-based, virtual reality-ready clinical training platform with VR simulations, simulation center…

Arboretum_JDJuly 26, 2021

EQRx News Page

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration

Collaboration combines Exscientia’s leading AI-driven drug discovery capabilities and EQRx’s innovative development and commercialization model…

Arboretum_JDJune 25, 2021

News

Success Begins Here

Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRX

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

New VR Training From Health Scholars & The American Academy of Pediatrics Aims to Help EMS Save Children’s Lives

EQRx to Accelerate Growth with $1.8B Raise through Proposed Combination with CM Life Sciences III

Julian Harris, Deerfield & ConcertoCare, on Innovating Elder Care

EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines

Strata Oncology Completes $90 Million Series C Financing

Pear Therapeutics Announces Publication of Data Analysis Showing Real-World Cost Impact of ReSET-O®

Health Scholars’ Strengthens EMS Portfolio to Meet Virtual Learning Demand

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration

News & Insights

ARCHIVES